SERPINA12 ELISA Kit

Produktnummer ABIN2745502

Produktdetails SERPINA12 ELISA Kit

Target: SERPINA12 (serpin Peptidase Inhibitor, Clade A (Alpha-1 Antiproteinase, Antitrypsin), Member 12 (SERPINA12))

Reaktivität: Human

Nachweismethode: Colorimetric

Methodentyp: Sandwich ELISA

Detektionsbereich: 0.016-1 ng/mL

Untere Nachweisgrenze: 0.016 ng/mL

Applikation: ELISA

Proben: Cell Culture Supernatant, Plasma, Serum

Analytische Methode: Quantitative

Spezifität: Detects human vaspin.

Kreuzreaktivität: Human

Kreuzreaktivität (Details): Does not cross-react with human RBP4, human adiponectin, human Nampt, human leptin or human RELM-beta.

Sensitivität: 12 pg/mL

Produktmerkmale: Vaspin (human) ELISA Kit

Anwendungsinformationen

Plattentyp: Pre-coated

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Lagerung: 4 °C

Informationen zur Lagerung: Short Term Storage: +4°C
Long Term Storage: +4°C
12 months after the day of manufacturing. See expiry date on ELISA Kit box.

Details zu SERPINA12

Target: SERPINA12 (serpin Peptidase Inhibitor, Clade A (Alpha-1 Antiproteinase, Antitrypsin), Member 12 (SERPINA12))

Andere Bezeichnung: Vaspin (SERPINA12 Produkte)

Synonyme: SERPINA12 ELISA Kit, 4632419J12Rik ELISA Kit, OL-64 ELISA Kit, Ol-64 ELISA Kit, Ol64 ELISA Kit, serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 12 ELISA Kit, serpin family A member 12 ELISA Kit, serine (or cysteine) peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 12 ELISA Kit, serpin A12 ELISA Kit, SERPINA12 ELISA Kit, Serpina12 ELISA Kit, LOC612386 ELISA Kit

Hintergrund: Vaspin (Visceral adipose tissue-derived serpin, Serpin A12), a serine protease inhibitor (serpin), is an insulin-sensitizing adipocytokine that has been isolated from both visceral and subcutaneous white adipose tissue. Based on recent findings, vaspin is suggested to regulate immune responses and inflammation and was found to be correlated with various metabolic parameters. Human vaspin blood levels are significantly increased in type 2 diabetes mellitus and obese patients. Thus vaspin may represent a novel biomarker for obesity and impaired insulin sensitivity and might serve as a new therapeutic target of metabolic syndrome.

UniProt: Q8IW75